Seagen Wins Over English HTA Body With More Analyses & Lower Price For Tukysa

NICE now says that Tukysa should be made available on the National Health Service for advanced or metastatic breast cancer, and notes that the drug also offers “real hope” to people whose cancer has spread to their brain.